Acura Pharmaceuticals, Inc. (ACUR: Quote) reported a net loss applicable to common stockholders for the fourth-quarter of $1.62 million or $0.03 per share, narrower than $2.9 million or $0.06 per share in the year-ago quarter.
The company did not generate any revenue in the latest quarter, compared to $359, 000 generated in the prior year quarter.
Click here to receive FREE breaking news email alerts for Acura Pharmaceuticals Inc and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org